NHS National Generic Pharmaceuticals Wave 14a

NHS EnglandcontractContracts FinderRef CF-1251900D0O000000rwimUAASME suitablecomplete
View buyer

Estimated value

£562.2m

Awarded value

£208.0m

Awarded 14 Dec 2022

Suppliers

1

Lots

1

1 awarded

Published

18 Jan 2023

Deadline 18 Oct 2022

Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 14a Offer reference number: CM/PHG/22/5657 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Hospital Only Products: DLN & DNW 01/02/2023 - 31/01/2025 (24 Months) Housekeeping Products (Hospital Only): CESW 01/02/2023 - 30/09/2023 (8 Months) LSNE 01/02/2023 - 31/05/2024 (16 Months)

Scope

Reference
CF-1251900D0O000000rwimUAA
Total value
£562,201,004 excluding VAT
Commercial tool
Standalone contract
Contract dates
01 Feb 2023 to 31 Jan 2025
CPV classifications
33600000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
18 Oct 2022, 12:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£208.0m

Award date

14 Dec 2022

Contract start

01 Feb 2023

Contract end

31 Jan 2025

Awarded to
SL
Sandoz Ltd,Amarox Limited,Synchrony,Mylan,Lupin Healthcare (UK) Limited,Torbay Pharmaceuticals,Lucane Pharma,Celix Pharma Ltd.,Fresenius Kabi Limited,Mercury Pharmaceuticals Limited,Milpharm Ltd/aurobinbdo,GlaxoSmithKline UK Limited,medac Pharma LLP,Macure Pharma ApS,Teva UK Limited,Sun Pharma UK Ltd,Wockhardt UK Limited,Morningside Pharmaeuticals,Neon Healthcare Ltd,Flexipharm Austrading Limited,Martindale Pharma,Gerot Lannach UK Ltd,Roche Products Ltd,Thornton and Ross Ltd,Aventis Pharma ltd t/a Sanofi,Pierre Fabre Ltd,Kent Pharma Ltd,FLYNN PHARMA LTD,Zentiva Pharma UK Ltd,CST Pharma Limited,Intrapharm Laboratories Ltd,B. Braun Medical Limited,Glenmark Pharmaceuticals Europe Limited,ennogen healthcare ltd,Desitin Pharma Ltd,Cipla,Thea Pharmaceuticals Limited,Pfizer Ltd,Selective Supplies Ltd.,Baxter Healthcare Ltd,ROVI Biotech Ltd,Stirling Anglian Pharmaceuticals Ltd,Aguettant Ltd,Dr.Reddy's Laboratories (UK) Limited,Tillomed Laboratories ltd,Aspire Pharma Limited,Macleods Pharma UK Limited,Panpharma UK Limited,Janssen-Cilag Ltd,Lundbeck Limited,Colonis Pharma Ltd,Crescent Pharma Ltd,Aspen Pharmacare UK Limited,AGB Pharma,Seacross Pharmaceuticals Ltd,MSN Laboratories Europe Limited,AOP Orphan Ltd,Consilient Health Ltd,hameln pharma ltd,Biocon,Day Lewis Medical Ltd,Recordati Pharmaceuticals Ltd,Brown & Burk UK Ltd,Accord-UK Ltd,Arcadia Pharma Ltd T/A Arcadia Medical,Lipomed AG,MIP Pharma GmbH,Bowmed Ibisqus Limited,Sobi (Swedish Orphan Biovitrum Ltd),Ferring Pharmaceuticals Ltd,Bausch + Lomb (Pharma),Neuraxpharm UK Ltd,Correvio GmbH,Manx Healthcare Ltd,GH Pharma Ltd,Piramal Critical care Limited,Waymade PLC,PARI,Vantage Pharmaceuticals Ltd,Aristo Pharma Limited,Laboratorio Reig Jofre SA,Drugsrus Ltd,Chiesi Limited,Otsuka Pharmaceuticals UK Limited,Takeda UK Ltd,Waverley Pharma Europe Limited,Tetris Pharma Lts,Ascend Laboratories UK Ltd,Alturix,Beaumont Pharma Ltd,Phoenix Lab,Focus Pharmaceuticals Ltd,Bristol Myers Squibb,RPH Pharmaceuticals AB,P M Pharma,Kensington Pharma Ltd,Strides Pharma Uk LTD,LogixX Pharma Ltd,Torrent Pharma UK Ltd